Cytosolic Phospholipase A in Mouse Platelets

Clinical and Therapeutic Implications
  • Dennis A. Wong
  • Naonori Uozumi
  • Yoshihiro Kita
  • Takao Shimizu
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 525)


The role of cytosolic phospholipase A2α(cPLA2α) in the release of arachidonic acid (AA) from lipid membranes has been intensely studied [1], Its ubiquitous expression and precise regulation initially suggested a role in both the regulation of membrane phospholipids and its release, triggered by extracellular signaling, to be converted into potent intracellular and extracellular signaling molecules. The survival of cPLA2α knockout mice, however, suggested that this enzyme has a somewhat redundant role in the upkeep of lipid membranes narrowing its role to its function of providing sharp spikes of intracellular AA to enzymes (cyclooxygenases (COX), lipoxygenases (LOX)), which then produce potent autocrine and/or paracrine lipid mediators upon activation [2]. The multitude of lipid mediators that can be derived from the release of AA makes the study of the precise role of cPLA2α in vivo difficult to dissect. The results, however, of recent studies in knockout mice platelets point to a non-redundant role for cPLA2α in the generation of thromboxane A2 (TXA2) at levels needed to perform a paracrine function, vasoconstriction [3]. These findings provide a basis to understand a number of previous studies in various disease models. Further the separation autocrine and paracrine pathways of TXA2 generation provide a possible explanation for the therapeutic utility of low dose aspirin in the prevention of acute arterial vascular events and insight into the potential of inhibiting this enzyme as therapy for a number of vascular and inflammatory diseases.


Arachidonic Acid Wildtype Mouse Arachidonic Acid Release Cytosolic Phospholipase Arachidonic Acid Production 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Six DA, and Dennis EA, 2000. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta; 1488, no. 1-2:1.Google Scholar
  2. 2.
    Uozumi N, Kume K, Nagase T, N. Nakatani, S. Ishii, F. Tashiro, Y. Komagata, K. Maki, K. Ikuta, Y. Ouchi, J. Miyazaki, and T. Shimizu. 1997. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390, no. 6660:618.PubMedCrossRefGoogle Scholar
  3. 3.
    Wong, D.A., Y. Kita, N. Uozumi, and T. Shimizu. 2002. Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). J Exp Med 196, no. 3:349.PubMedCrossRefGoogle Scholar
  4. 4.
    Rao, A.K. 1998. Congenital disorders of platelet function: disorders of signal transduction and secretion. Am J Med Sci 316, no. 2:69.PubMedCrossRefGoogle Scholar
  5. 5.
    Thomas, D.W., R.B. Mannon, P.J. Mannon, A. Latour, J.A. Oliver, M. Hoffman, O. Smithies, B.H. Koller, and T.M. Coffman. 1998. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 102, no. 11:1994.PubMedCrossRefGoogle Scholar
  6. 6.
    Ichinose, F., R. Ullrich, A. Sapirstein, R.C. Jones, J.V. Bonventre, C.N. Serhan, K.D. Bloch, and W.M. Zapol. 2002. Cytosolic phospholipase A(2) in hypoxic pulmonary vasoconstriction. J Clin Invest 109, no. 11:1493.PubMedGoogle Scholar
  7. 7.
    Leslie, C.C. 1997. Properties and regulation of cytosolic phospholipase A2. J Biol Chem 272, no. 27:16709.PubMedCrossRefGoogle Scholar
  8. 8.
    Bunescu, A., J. Widman, R. Lenkei, P. Menyes, K. Levin, and N. Egberg. 2002. Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty. Clin Sci (Lond) 102, no. 3:279.CrossRefGoogle Scholar
  9. 9.
    Evangelista, V., A. Celardo, G. Dell’Elba, S. Manarini, A. Mironov, G. de Gaetano, and C. Cerletti. 1999. Platelet contribution to leukotriene production in inflammation: in vivo evidence in the rabbit. Thromb Haemost 81, no. 3:442.PubMedGoogle Scholar
  10. 10.
    Nagase, T., N. Uozumi, S. Ishii, K. Kume, T. Izumi, Y. Ouchi, and T. Shimizu. 2000. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol 1, no. 1:42.PubMedCrossRefGoogle Scholar
  11. 11.
    Nagase, T., N. Uozumi, S. Ishii, Y. Kita, H. Yamamoto, E. Ohga, Y. Ouchi, and T. Shimizu. 2002. A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat Med 8, no. 5:480.PubMedCrossRefGoogle Scholar
  12. 12.
    Chen, J., T.G. Diacovo, D.G. Grenache, S.A. Santoro, and M.M. Zutter. 2002. The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 161, no. 1:337.PubMedCrossRefGoogle Scholar
  13. 13.
    Holtkotter, O., B. Nieswandt, N. Smyth, W. Muller, M. Hafher, V. Schulte, T. Krieg, and B. Eckes. 2002. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 277, no. 13:10789.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Dennis A. Wong
    • 1
  • Naonori Uozumi
    • 4
  • Yoshihiro Kita
    • 2
  • Takao Shimizu
    • 3
  1. 1.Department of MedicineUniversity of ChicagoChicagoUSA
  2. 2.Department of Biochemistry and Molecular Biology, Faculty of MedicineThe University of Tokyo, CREST of JSTTokyoJapan
  3. 3.Department of Biochemistry and Molecular Biology, Faculty of MedicineThe University of TokyoBunkyo-ku Hongo, TokyoJapan
  4. 4.Department of Biochemistry and Molecular Biology, Faculty of MedicineThe University of TokyoJapan

Personalised recommendations